+499.5%
MRNA vs HDB
-34.6%
+534.1%
-34.2%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 1y.
| Period | Portfolio | HDB | Excess | Alpha |
|---|---|---|---|---|
| 1D | -2.2% | -0.4% | -1.8% | -2.1% |
| 7D | +5.5% | +0.4% | +5.0% | +5.3% |
| 30D | +158.7% | -2.8% | +161.5% | +161.5% |
| 3M | +182.1% | -3.5% | +185.7% | +187.6% |
| 6M | +151.8% | -24.7% | +176.5% | +159.9% |
| YTD | +393.6% | -36.6% | +430.1% | +410.3% |
| 1Y | +499.5% | -34.4% | +533.8% | +530.8% |
| All | +499.5% | -34.6% | +534.1% | +530.8% |
Cumulative growth
Daily Returns
Daily percentage return beside HDB.
Daily Out/Under-Performance
Portfolio return minus HDB return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × HDB return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 1y: compounded portfolio wealth divided by compounded HDB wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
1y analysis · Full analysis span regression · 6 months rolling